Modulatory role of the epinergic system in the neuroendocrine-immune system function

NeuroImmunoModulation

Volumn 8, Issue 2, 2000, Pages 98-106

  Giovambattista, Andrés ^a,b   Chisari, Andrea N ^a,b   Gaillard, Rolf C ^c   Spinedi, Eduardo ^a,d  

^a Universidad Provincial del Sudoeste   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Instituto Multidisciplinario de Biologia Celular   (Argentina)

Author keywords

Adrenocorticotropic hormone; Carbohydrate; Corticotropin releasing hormone; Cytokines; Glucocorticoids; Phenylethanolamine N methyltransferase; Vasopressin

Indexed keywords

1,2,3,4 TETRAHYDRO 7 ISOQUINOLINESULFONAMIDE; 7,8 DICHLORO 1,2,3,4 TETRAHYDROISOQUINOLINE; ARGININE; CONCANAVALIN A; CORTICOTROPIN; CYTOKINE; ENDOTOXIN; GLUCOCORTICOID; METHYLTRANSFERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ADENOHYPOPHYSIS; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CYTOKINE PRODUCTION; ENDOTOXEMIA; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; IMMUNE SYSTEM; IMMUNOMODULATION; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033798528     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026459     Document Type: Article

References (50)

1. Bateman A, Singh A, Kral T, Solomon S: The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989;10:92-112.
2. Dunn AJ, Wang J, Ando T: Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 1999;461:117-127.
3. Dunn AJ, Wang J: Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 1995;2:319-328.
4. Plotsky PM, Cunningham ET, Widmaier EP: Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 1989;10:437-548.
5. Koff WC, Dunegan MA: Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 1985;135:350-354.
6. Ignatowski TA, Gallant S, Spengler RN: Temporal regulation by adrenergic receptor stimulation of macrophage-derived tumor necrosis factor (TNF) production post-LPS challenge. J Neuroimmunol 1996;65:107-117.
7. McKechnie K, Dean HG, Furman BL, Parrat JR: Plasma catecholamines during endotoxin infusion in conscious unrestrained rats: Effects of adrenal demedullation and/or guanethidine treatment. Circ Shock 1985;17:85-94.
8. Qi M, Zhou ZZ, Wurster RD, Jones SB: Mechanisms involved in the rapid dissipation of plasma epinephrine response to bacterial endotoxin administration in conscious rat. Am J Physiol 1991;261:R1431-R1437.
9. Dinarello CA: Interleukin-1. Rev Infect Dis 1984;6:51-95.
10. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M: Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat hypothalamus. J Neurosci 1993;13:3574-3581.
11. Smagin GN, Swiergiel AH, Dunn AJ: Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in the rat hypothalamus: Comparison with plasma corticosterone. Psychoneuroendocrinology 1996;21:83-93.
12. Delrue-Perollet C, Li KS, Vitiello S, Neveu PJ: Peripheral catecholamines are involved in the neuroendocrine and immune effects of LPS. Brain Behav Immun 1995;9:149-162.
13. Pendleton RG, Kaiser C, Gessner G: Studies on adrenal phenylethanolamine-N-methyltransferase (PNMT) with SKF-64139, a selective inhibitor. J Pharmacol Exp Ther 1976; 197:623-632.
14. Pendleton RG, Gessner G, Weiner G, Jenkins B, Sawyer J, Bondinell W, Intoccia A: Studies on SKF-29661, an organ specific inhibitor of adrenal phenylethanolamine-N-methyltransferase. J Pharmacol Exp Ther 1979;208:24-30.
15. Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC: Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: Evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 1992; 131:2430-2436.
16. Spinedi E, Giacomini M, Jacquier M-C, Gaillard RC: Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: Evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 1991;53: 160-170.
17. Singh VK: Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol 1989;23:257-262.
18. Hodgkinson SC, Allolio B, Landon J, Lowry PJ: Development of non-extracted two-site immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. Biochem J 1984;218:703-711.
19. Flick DA, Gifford GE: Comparison of in vitro cell cytotoxic assay for tumor necrosis factor. J Immunol Methods 1984;68:167-175.
20. Zar JH: Biostatistical Analysis. Englewood Cliffs, Prentice-Hall, 1974.
21. Kalra SP, Crowley WR: Epinephrine synthesis inhibitors block naloxone-induced LH release. Endocrinology 1982;111:1403-1405.
22. Spinedi E, Johnston CA, Chisari A, NegroVilar A: Role of central epinephrine on the regulation of corticotropin-releasing-factor and adrenocorticotropin secretion. Endocrinology 1988;122:1977-1983.
23. Spinedi E, Hadid R, Daneva T, Gaillard RC: Cytokines stimulate the CRH but not the vasopressin neuronal system: Evidence for a median eminence site of interleukin-6 action. Neuroendocrinology 1992;56:46-53.
24. Sternberg EM, Young WS III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL: A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell-wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-4775.
25. Zelazwoski P, Smith MA, Gold PW, Chrousos GP, Wilder RL, Sternberg EM: In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/ N) rats. Neuroendocrinology 1992;56:474-482.
26. Spinedi E, Salas M, Chisari A, Perone M, Carino M, Gaillard RC: Sex differences in the hypothalamo-pituitary-adrenal axis response to inflammatory and neuroendocrine stressors. Neuroendocrinology 1994;60:609-617.
27. Berkenbosch F, Vermes I, Buijs RM, Tilders FJH: Vasopressin is not involved in the catecholamine-induced release of ACTH, α-MSH, and β-endorphin from the rat pituitary gland. Neuroendocrinology 1983;37:117-121.
28. Engberg G, Elam M, Svensson TH: Effect of adrenaline synthesis inhibition on brain noradrenaline neurons in the locus coeruleus. Brain Res 1981;223:49-58.
29. 2-Adrenoceptor-blocking action of the phenylethanolamine-N-methyltransferase inhibitor SKF-64139. J Pharm Pharmacol 1981;33:187-188.
30. Saavedra JM, Palkovits M, Brownstein MJ, Axelrod J: Localization of phenylethanolamine-N-methyltransferase in the rat brain nuclei. Nature 1974;248:695-696.
31. Agnati LF, Fuxe K, Yu ZY, Harfstrand A, Okret S, Wikstrom AC, Goldstein M, Zoli M, Vale W, Gustafsson JA: Morphometrical analysis of the distribution of corticotropin releasing factor, glucocorticoid receptor and phenylethanolamine-N-methyltransferase immunoreactivity structures in the paraventricular hypothalamic nucleus of the rat. Neurosci Lett 1985;54:147-152.
32. Guillaume V, Conte-Devolx B, Szafarczyk A, Malaval F, Pares-Herbute N, Grino M, Alonso A, Assenmacher I, Oliver C: The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines. Neuroendocrinology 1987;46:143-146.
33. Fuller RW: The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 1992;13:250-270.
34. Givalois L, Becq H, Siaud P, Ixart G, Assenmacher I, Barbanel G: Serotoninergic and suprachiasmatic nucleus involvement in the corticotropic response to systemic endotoxin challenge in rats. J Neuroendocrinol 1999;11:629-636.
35. Conde GL, Renshaw D, Lightman SL, Harbuz MS: Serotonin depletion does not alter lipopolysaccharide-induced activation of the rat paraventricular nucleus. J Endocrinol 1998; 156:245-251.
36. Guillon G, Trueba M, Jourbet D, Grazzini E, Chouinard L, Cote M, Payet MD, Manzoni O, Barberis C, Robert M, Gallo-Payet N: Vasopressin stimulates steroid secretion in human adrenal glands: Comparison with angiotensin-II effects. Endocrinology 1995;136:1285-1295.
37. Salas MA, Evans SW, Levell MJ, Whicher JT: Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol 1990;79: 470-473.
38. Chu PC, Lin MT, Leu SY: Decreasing brain epinephrine levels with 2-cyclooctyl-2-hydroxyethylamine induces hyperglycemia in rats. Neuroendocrinology 1985;41:181-185.
39. 2-adrenergic receptors. Biochem Pharmacol 1977;16:1813-1816.
40. Song DK, Im YB, Jung JS, Suh HW, Huh SO, Park SW, Wie MB, Kim YH: Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice. J Neurochem 1999;72:1625-1633.
41. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL: Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990;145:1430-1434.
42. van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJH: Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994;62:2046-2050.
43. Kvetnansky R, Sun CL, Lake CR, Thoa N, Torda T, Kopin IJL: Effects of handling and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-β-hydroxylase. Endocrinology 1978;103:1868-1874.
44. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS: Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993; 133:2523-2530.
45. Soszynski D, Kozak W, Conn CA, Rudolph K, Kluger MJ: Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology 1996;63:459-467.
46. Felten DL, Ackerman KD, Wiegand SJ, Felten SY: Noradrenergic sympathetic innervation of the spleen. I. Nerve fibers associated with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosci Res 1987;18:28-36.
47. Leposavic G, Micic M, Ugresic N, Bogojevic M, Isakovic K: Components of sympathetic innervation of the rat thymus during late fetal and postnatal development: Histofluorescence and biochemical study. Thymus 1992;19:77-87.
48. Josefsson E, Bergquist R, Ekman R, Tarakowski A: Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 1996;88:140-146.
49. Ramachandra RN, Sehon AH, Berczi I: Neurohormonal host defense in endotoxic shock. Brain Behav Immun 1992;6:157-169.
50. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984;5:25-44.